Christina Rossi
Direttore operativo presso BLUEPRINT MEDICINES CORPORATION
Patrimonio netto: 3 M $ in data 31/05/2024
Posizioni attive di Christina Rossi
Società | Posizione | Inizio | Fine |
---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Direttore operativo | 04/04/2022 | - |
Corporate Officer/Principal | 29/10/2018 | 04/04/2022 | |
XILIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/04/2021 | - |
Independent Dir/Board Member | 01/04/2021 | - |
Storia della carriera di Christina Rossi
Precedenti posizioni note di Christina Rossi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2012 | 01/10/2018 |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Corporate Officer/Principal | 01/01/2005 | 01/01/2010 |
Formazione di Christina Rossi
Duke University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Christina Rossi
- Esperienza